Rxii offering
WebOct 1, 2024 · RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self … WebFeb 5, 2015 · RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a biotechnology company focused on discovering and developing innovative therapeutics, primarily in the area of dermatology and ophthalmology ...
Rxii offering
Did you know?
WebApr 1, 2024 · RXi Pharmaceuticals - RXII Competitors Notice: This company has been marked as potentially delisted and may not be actively trading. Compare Today's Range $5.62 $6.03 50-Day Range $0.36 $0.50 52-Week Range $0.31 $7.70 Volume 7,982 shs Average Volume 1.73 million shs Market Capitalization $24.62 million P/E Ratio N/A … WebOct 8, 2024 · On October 3rd, 2024 RXi Pharmaceuticals Corp. (RXII) announced it had closed its $15 million public underwriting. 3.725 million shares were issued at $0.70 per share and 17.702 million prefunded ...
WebApr 17, 2015 · RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a biotechnology company focused on discovering and developing innovative therapeutics primarily in the area of dermatology and ophthalmology that ... WebStock analysis for Phio Pharmaceuticals Corp (RXII) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebAug 4, 2014 · Prior to the sector downturn, RXII was trading in the 5.50-6.50 range. This area is around a $100-million market cap, which is not unreasonable for a company with ~$14 million in cash and a drug ... WebAug 1, 2024 · RXi announced in January 2024 that it would exclusively focus on developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi therapeutic platform. As such, it...
WebRXII Rxi Pharmaceuticals Corp. (MM) RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-allotment Optio... RXi Pharmaceuticals Announces Closing of $11.5 Million Underwritten Public Offering and Full Exercise of Over-allotment Option PR Newswire MARLBOROUGH, Mass., Dec. 21, 2016 ...
WebFeb 13, 2008 · RXi Pharmaceuticals Corp. (Nasdaq: RXII) filed an amended registration statement with the SEC for an initial public offering of its common stock.The proposed maximum aggregate offering price is ... honda ridgeline rims and tiresWebOct 3, 2024 · RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self … hitman alert proWebApr 11, 2024 · RXi Pharmaceuticals (NASDAQ:RXII) has a market capitalization of $25.21 million and generates $10,000.00 in revenue each year. The biotechnology company earns … honda ridgeline roof rack installationWebOct 1, 2024 · RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self … hitman agente 47 repartoWebMay 11, 2024 · RXi reported revenues of $23,000 for the quarter from grants related to BioAxone’s work in spinal cord injury, compared to zero in revenues in 1Q:17. Following the availability of the trial ... honda ridgeline roof rack installWebFind the latest RXi Pharmaceuticals Corporation (RXII) stock quote, history, news and other vital information to help you with your stock trading and investing. hitman a light headacheWebMar 1, 2011 · WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII) today announced that it is offering to sell shares of its common stock and … honda ridgeline roof rack system